ES474764A0 - A PROCEDURE FOR THE PREPARATION OF PHTHALAZINES. - Google Patents

A PROCEDURE FOR THE PREPARATION OF PHTHALAZINES.

Info

Publication number
ES474764A0
ES474764A0 ES474764A ES474764A ES474764A0 ES 474764 A0 ES474764 A0 ES 474764A0 ES 474764 A ES474764 A ES 474764A ES 474764 A ES474764 A ES 474764A ES 474764 A0 ES474764 A0 ES 474764A0
Authority
ES
Spain
Prior art keywords
phthalazines
procedure
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
ES474764A
Other languages
Spanish (es)
Inventor
Simon Fraser Campbell
John Christopher Danilewicz
Allan Leslie Ham
Jhon Kendrick Stubbs
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Corp
Pfizer Inc
Original Assignee
Pfizer Corp
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Corp, Pfizer Inc filed Critical Pfizer Corp
Publication of ES474764A0 publication Critical patent/ES474764A0/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/40—Acylated substituent nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
    • C07D211/28—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms to which a second hetero atom is attached
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/42—Radicals substituted by singly-bound nitrogen atoms having hetero atoms attached to the substituent nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/30—Phthalazines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/30—Phthalazines
    • C07D237/32—Phthalazines with oxygen atoms directly attached to carbon atoms of the nitrogen-containing ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)
ES474764A 1977-11-03 1978-11-02 A PROCEDURE FOR THE PREPARATION OF PHTHALAZINES. Pending ES474764A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB4567077 1977-11-03

Publications (1)

Publication Number Publication Date
ES474764A0 true ES474764A0 (en) 1980-08-16

Family

ID=10438118

Family Applications (5)

Application Number Title Priority Date Filing Date
ES474764A Pending ES474764A0 (en) 1977-11-03 1978-11-02 A PROCEDURE FOR THE PREPARATION OF PHTHALAZINES.
ES479992A Expired ES479992A1 (en) 1977-11-03 1979-04-26 Novel phthalazine derivative*its manufacture and phosphodiesterase cardiac stimulant comprising it
ES479994A Expired ES479994A1 (en) 1977-11-03 1979-04-26 Novel phthalazine derivative*its manufacture and phosphodiesterase cardiac stimulant comprising it
ES479993A Expired ES479993A1 (en) 1977-11-03 1979-04-26 Novel phthalazine derivative*its manufacture and phosphodiesterase cardiac stimulant comprising it
ES479991A Expired ES479991A1 (en) 1977-11-03 1979-04-26 Novel phthalazine derivative*its manufacture and phosphodiesterase cardiac stimulant comprising it

Family Applications After (4)

Application Number Title Priority Date Filing Date
ES479992A Expired ES479992A1 (en) 1977-11-03 1979-04-26 Novel phthalazine derivative*its manufacture and phosphodiesterase cardiac stimulant comprising it
ES479994A Expired ES479994A1 (en) 1977-11-03 1979-04-26 Novel phthalazine derivative*its manufacture and phosphodiesterase cardiac stimulant comprising it
ES479993A Expired ES479993A1 (en) 1977-11-03 1979-04-26 Novel phthalazine derivative*its manufacture and phosphodiesterase cardiac stimulant comprising it
ES479991A Expired ES479991A1 (en) 1977-11-03 1979-04-26 Novel phthalazine derivative*its manufacture and phosphodiesterase cardiac stimulant comprising it

Country Status (20)

Country Link
JP (1) JPS5498783A (en)
AR (3) AR219561A1 (en)
AT (1) AT365184B (en)
AU (1) AU507007B2 (en)
BE (1) BE871770A (en)
CA (1) CA1114379A (en)
DE (1) DE2847621A1 (en)
DK (1) DK487978A (en)
ES (5) ES474764A0 (en)
FI (1) FI783326A (en)
FR (1) FR2407927A1 (en)
IE (1) IE47481B1 (en)
IL (1) IL55844A (en)
IT (1) IT1101279B (en)
LU (1) LU80458A1 (en)
NL (1) NL7810864A (en)
PH (1) PH14659A (en)
PT (1) PT68734A (en)
SE (1) SE7811322L (en)
YU (3) YU253678A (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6215356U (en) * 1985-07-15 1987-01-29
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
US20060211707A1 (en) * 2003-05-07 2006-09-21 Hamed Aissaoui Piperazine-alkyl-ureido derivatives
EP2218442A1 (en) 2005-11-09 2010-08-18 CombinatoRx, Inc. Methods, compositions, and kits for the treatment of ophthalmic disorders
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
MX354786B (en) 2007-06-04 2018-03-21 Synergy Pharmaceuticals Inc AGONISTS OF GUANYLATE CYCLASE USEFUL FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS, INFLAMMATION, CANCER and OTHER DISORDERS.
CA2726917C (en) 2008-06-04 2018-06-26 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
WO2010009319A2 (en) 2008-07-16 2010-01-21 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
US9580471B2 (en) 2011-03-01 2017-02-28 Synergy Pharmaceuticals, Inc. Process of preparing guanylate cyclase C agonists
WO2013106547A1 (en) 2012-01-10 2013-07-18 President And Fellows Of Harvard College Beta-cell replication promoting compounds and methods of their use
US9545446B2 (en) 2013-02-25 2017-01-17 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase and their uses
EP2970384A1 (en) 2013-03-15 2016-01-20 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
WO2014151200A2 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
JP6606491B2 (en) 2013-06-05 2019-11-13 シナジー ファーマシューティカルズ インコーポレイテッド Ultra high purity agonist of guanylate cyclase C, method for producing and using the same
JP6694385B2 (en) 2013-08-09 2020-05-13 アーデリクス，インコーポレーテッド Compounds and methods for inhibiting phosphate transport
WO2020237096A1 (en) 2019-05-21 2020-11-26 Ardelyx, Inc. Combination for lowering serum phosphate in a patient

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1293565A (en) * 1969-05-03 1972-10-18 Aspro Nicholas Ltd Aminophthalazines and pharmaceutical compositions thereof

Also Published As

Publication number Publication date
ES479992A1 (en) 1980-09-01
CA1114379A (en) 1981-12-15
YU253678A (en) 1983-02-28
DE2847621A1 (en) 1979-05-17
FR2407927B1 (en) 1982-07-16
SE7811322L (en) 1979-05-04
FR2407927A1 (en) 1979-06-01
YU211682A (en) 1983-02-28
AU4127678A (en) 1979-05-17
JPS5498783A (en) 1979-08-03
AR217577A1 (en) 1980-03-31
IT7829369A0 (en) 1978-11-02
LU80458A1 (en) 1980-05-07
ES479993A1 (en) 1980-08-16
ES479991A1 (en) 1980-08-16
ATA783978A (en) 1981-05-15
IE782166L (en) 1979-05-03
BE871770A (en) 1979-05-03
AU507007B2 (en) 1980-01-31
FI783326A (en) 1979-05-04
AR219561A1 (en) 1980-08-29
AT365184B (en) 1981-12-28
IL55844A (en) 1982-05-31
ES479994A1 (en) 1980-08-16
IE47481B1 (en) 1984-04-04
PH14659A (en) 1981-10-20
DK487978A (en) 1979-05-04
JPS5538352B2 (en) 1980-10-03
NL7810864A (en) 1979-05-07
YU211582A (en) 1983-02-28
PT68734A (en) 1978-12-01
IT1101279B (en) 1985-09-28
IL55844A0 (en) 1979-01-31
AR217578A1 (en) 1980-03-31

Similar Documents

Publication Publication Date Title
ES491534A0 (en) A PROCEDURE FOR THE PREPARATION OF NEW METHANODIOL BISTERS.
ES486786A0 (en) A PROCEDURE FOR THE PREPARATION OF CARBOXIALKYL-DIPEP-TIDOS.
ES497304A0 (en) A PROCEDURE FOR THE PREPARATION OF NEW DERIVATIVES OF DIARILAMINO-FLUORANO.
ES479988A0 (en) A PROCEDURE FOR THE PREPARATION OF NEW DERIVATIVES - HETE ROCICLICOS.
ES487843A0 (en) A PROCEDURE FOR THE PREPARATION OF IMIDA-ZOL DERIVATIVES.
ES494131A0 (en) A PROCEDURE FOR THE PREPARATION OF DIARYLTHIOPHENES.
ES491944A0 (en) A PROCEDURE FOR THE PREPARATION OF TIENAMICINES.
ES488886A0 (en) A PROCEDURE FOR THE PREPARATION OF DERIVATIVES PENEMCARBOXILICOS.
AR221251A1 (en) A PROCEDURE FOR THE PREPARATION OF 4-PIPERIDINE-6,7-DIALCOXY-QUINAZOLINE DERIVATIVES
ES474764A0 (en) A PROCEDURE FOR THE PREPARATION OF PHTHALAZINES.
ES495586A0 (en) A PROCEDURE FOR THE PREPARATION OF OXAZO- LIDONA- OR TIAZOLIDONE DERIVATIVES.
ES495163A0 (en) A PROCEDURE FOR THE PREPARATION OF CARBOESTIRILE DERIVATIVES.
ES491835A0 (en) A PROCEDURE FOR THE PREPARATION OF MONO-Y-DI-ESTERES DESACAROSA.
ES490722A0 (en) A PROCEDURE FOR THE PREPARATION OF NEW PIRIDAZINE DERIVATIVES.
ES507997A0 (en) A PROCEDURE FOR THE PREPARATION OF NEW QUINOLEIN DERIVATIVES.
ES489470A0 (en) A PROCEDURE FOR THE PREPARATION OF 9-AMINOALKYLFLUORE-NO
ES491618A0 (en) PROCEDURE FOR THE PREPARATION OF A CHLORINE-2-PROPIONATE OF AL-COHYL
ES493111A0 (en) A PROCEDURE FOR THE PREPARATION OF NEW HETE-ROCICLIC PHENOXYAMINS
ES491370A0 (en) A PROCEDURE FOR THE PREPARATION OF PIRIDIZINOBENZODIAZEPINES
ES493506A0 (en) A PROCEDURE FOR THE PREPARATION OF DESACETIL-CEFALOSPO-RINA C
ES495589A0 (en) A PROCEDURE FOR THE PREPARATION OF IMIDA-LOL DERIVATIVES.
ES490277A0 (en) A PROCEDURE FOR THE PREPARATION OF AMINOETERES.
ES480121A0 (en) A PROCEDURE FOR THE PREPARATION OF NEW QUINAZOLINE DERIVATIVES.
ES489880A0 (en) A PROCEDURE FOR THE PREPARATION OF A TRIHALOMETILCARBONATE
ES494130A0 (en) A PROCEDURE FOR THE PREPARATION OF NEW BENZOXOCINE DERIVATIVES.